Amgen (AMGN) Gets a Hold from Mizuho Securities

Tip Ranks
2025.11.20 20:15
portai
I'm PortAI, I can summarize articles.

Mizuho Securities maintained a Hold rating on Amgen with a $280 price target. Cantor Fitzgerald also issued a Hold rating, while Piper Sandler reiterated a Buy rating on Amgen.

Mizuho Securities analyst maintained a Hold rating on Amgen today and set a price target of $280.00.

TipRanks Black Friday Sale

  • Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
  • Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off

In addition to Mizuho Securities, Amgen also received a Hold from Cantor Fitzgerald’s Carter Gould in a report issued on November 6. However, on November 14, Piper Sandler reiterated a Buy rating on Amgen (NASDAQ: AMGN).

Source: Tip Ranks The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.